PRME
Price
$2.16
Change
+$0.09 (+4.35%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
283.6M
43 days until earnings call
RXRX
Price
$4.83
Change
-$0.19 (-3.78%)
Updated
Jun 23 closing price
Capitalization
1.96B
49 days until earnings call
Interact to see
Advertisement

PRME vs RXRX

Header iconPRME vs RXRX Comparison
Open Charts PRME vs RXRXBanner chart's image
Prime Medicine
Price$2.16
Change+$0.09 (+4.35%)
Volume$19.84K
Capitalization283.6M
Recursion Pharmaceuticals
Price$4.83
Change-$0.19 (-3.78%)
Volume$21.55M
Capitalization1.96B
PRME vs RXRX Comparison Chart in %
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. RXRX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a StrongBuy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (PRME: $2.16 vs. RXRX: $4.83)
Brand notoriety: PRME and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 179% vs. RXRX: 89%
Market capitalization -- PRME: $283.6M vs. RXRX: $1.96B
PRME [@Biotechnology] is valued at $283.6M. RXRX’s [@Biotechnology] market capitalization is $1.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRME is a better buy in the short-term than RXRX.

Price Growth

PRME (@Biotechnology) experienced а +44.00% price change this week, while RXRX (@Biotechnology) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.24%. For the same industry, the average monthly price growth was +27.91%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

PRME is expected to report earnings on Aug 06, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.96B) has a higher market cap than PRME($284M). PRME YTD gains are higher at: -26.027 vs. RXRX (-28.550). PRME has higher annual earnings (EBITDA): -200M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. PRME (144M). RXRX has less debt than PRME: RXRX (92.9M) vs PRME (121M). RXRX has higher revenues than PRME: RXRX (59.8M) vs PRME (3.85M).
PRMERXRXPRME / RXRX
Capitalization284M1.96B14%
EBITDA-200M-524.77M38%
Gain YTD-26.027-28.55091%
P/E RatioN/AN/A-
Revenue3.85M59.8M6%
Total Cash144M500M29%
Total Debt121M92.9M130%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMERXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDTCX30.79N/A
N/A
Fidelity Advisor Diversified Stock C
RSNYX37.85N/A
N/A
Victory Global Energy Transition Y
SCWCX56.28N/A
N/A
American Funds SMALLCAP World C
ACSMX10.74N/A
N/A
Advisors Capital Small/Mid Cap
MXEVX11.58N/A
N/A
Empower Core Strategies Intl Eq Inv

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+4.35%
CRSP - PRME
63%
Loosely correlated
+2.94%
BEAM - PRME
57%
Loosely correlated
-0.30%
RXRX - PRME
56%
Loosely correlated
-3.78%
CRBU - PRME
53%
Loosely correlated
-1.49%
CCCC - PRME
52%
Loosely correlated
+3.52%
More